论文部分内容阅读
降血脂药苯扎贝特缓释制剂的推荐剂量为每日3次,每次200mg或每日1次,每次400mg。它在高甘油三酯血症和高胆固醇血症患者中各能产生持久的血液甘油三酯和胆固醇浓度的下降。初步研究表明,本品缓释剂400mg每日1次的效果与每次200mg每日3次的效果一样。对任何类型的高脂蛋白血症病人,苯扎贝特能增加血浆HDL-胆固醇的浓度。这种作用可发生在原发性高脂蛋白血症或继发于糖尿病或肾脏病的高脂蛋白血症,虽然在后一组病人需要调节剂量。长期使用(2～4年)苯扎贝特可
The recommended dosage of the lipid-lowering drug bezafibrate sustained-release preparation is 200 mg or once daily, 400 mg each time, three times a day. It can produce long-lasting blood triglyceride and cholesterol concentrations in patients with hypertriglyceridemia and hypercholesterolemia each. Preliminary studies have shown that this product sustained-release agent 400mg once daily effect and 200mg 3 times a day the same effect. Bezafibrate increases plasma HDL-cholesterol levels in any type of hyperlipoproteinemia. This effect can occur in patients with primary hyperlipoproteinemia or hyperlipoproteinemia secondary to diabetes or nephropathy, although dosage adjustments are required in the latter group of patients. Long-term use (2 to 4 years) bezafibrate can